# Tirzepatide Dosing Chart and Titration Explained

**By telos rx Editorial Team** · 2026-11-17

**A tirzepatide dosing chart shows how the brand label raises the dose in small steps. Your own dose and pace are always set by your prescriber, never by a chart online. [See how telos rx providers handle titration](https://telosrx.com/pages/lp2tirzepatide).**

_Written by the telos rx Editorial Team. Last reviewed: 17 November 2026._

Search for a tirzepatide dosing chart and you will find dozens of tables. Many convert doses into syringe markings or volumes. Some are copied from the brand label. Others are not.

This guide explains how titration works, what the Zepbound label actually says, and why a generic chart can be risky with compounded medication. It will not give you a schedule to follow. That job belongs to your prescriber.

## What "titration" means

Titration means starting a medicine at a low dose and raising it gradually. The goal is to let your body adjust before the dose goes up.

With tirzepatide, the main reason is the gut. Nausea, vomiting and diarrhea are most common when the dose changes. A slower climb gives your digestive system time to adapt.

Titration is also about finding the right dose for you. That is not always the highest dose. It is the dose that balances benefit and side effects for your situation.

## What the Zepbound label says about dose escalation

Zepbound is the FDA-approved brand of tirzepatide for chronic weight management. Its [prescribing information on DailyMed](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=487cd7e7-434c-4925-99fa-aa80b1cc776b) describes a stepwise approach for prescribers.

In summary, the label starts with a low weekly dose for the first four weeks. It then raises the dose in small, equal steps, each after at least four weeks at the current dose. It lists three maintenance dose options for weight management and a maximum weekly dose.

The label also tells prescribers to consider treatment response and tolerability when choosing the maintenance dose. In other words, the label itself expects individual decisions. Nobody is meant to march to the top by default.

Mounjaro, the brand for type 2 diabetes, has its own label. Diabetes care belongs with your own clinician, who will follow that label.

## Why we do not publish a dose-by-week chart

Charts look helpful, but they leave out the things that matter most. Here is why we explain the approach instead of printing a schedule.

-   **Every patient is different.** Side effects, other medicines and health conditions change how fast a provider moves.
-   **Compounded products vary.** Concentrations differ between pharmacies and programs. A conversion that is right for one product can be wrong for another.
-   **Dosing errors cause harm.** The FDA reports adverse events, some needing hospital care, linked to dosing mistakes with compounded GLP-1 products.
-   **Labels change.** Brand labels are updated over time. A chart copied a year ago may be out of date.

If you see a chart that converts doses into syringe markings, do not use it to set your own dose. Ask your prescriber or pharmacist instead.

## Key terms in plain English

| Term | What it means | Who decides |
| --- | --- | --- |
| Starting dose | The low dose used while your body adjusts | Your prescriber |
| Titration step | A planned increase after a period at the current dose | Your prescriber |
| Hold | Staying at the same dose for longer, often because of side effects | Your prescriber, with your feedback |
| Step back | Returning to a lower dose if a step is not tolerated | Your prescriber |
| Maintenance dose | The dose you stay on once titration ends | Your prescriber |
| Maximum dose | The highest weekly dose on the brand label | Set by the label; your prescriber decides if it applies |

Notice the pattern in the last column. Your role is to report how you feel. The decisions sit with a licensed clinician.

## How providers typically approach titration

Clinicians usually follow a few common principles, guided by the label and your response.

1.  **Start low.** The first weeks are about tolerance, not results.
2.  **Move slowly.** Steps are spaced out so side effects can settle.
3.  **Check in before each step.** Your provider asks about nausea, bowel changes, appetite and energy.
4.  **Hold when needed.** If side effects are bothersome, staying put is common and reasonable.
5.  **Stop at the right dose.** Many people stay below the maximum if their current dose works for them.

Our guide to [side effects during dose escalation](https://telosrx.com/blogs/glp1/tirzepatide-dose-escalation-side-effects) covers what clinicians typically suggest at each stage.

Titration guided by a licensed provider

With telos rx, your provider sets and adjusts your tirzepatide dose based on your feedback. Compounded tirzepatide is not FDA-approved, and any prescription is subject to medical approval by a licensed provider.

[Explore the program](https://telosrx.com/pages/lp2tirzepatide)

## Compounded tirzepatide and dosing

Compounded tirzepatide is not FDA-approved. It is prepared by a state-licensed pharmacy for an individual patient with a prescription. It is not the same product as Zepbound or Mounjaro.

Because compounded products can differ in strength and format, the dose you see on a brand chart may not match how your product is labeled. Your prescriber and pharmacy are the only reliable sources for your dose.

The FDA's [guidance on compounded GLP-1 drugs](https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss) notes reports of patients receiving doses beyond the brand label, more often or with faster increases. It asks prescribers to be vigilant about dosing and titration.

At telos rx, prescribed medication ships ready to inject. You are not asked to prepare, mix or measure anything. Your provider sets the dose and adjusts it over time.

## Signs your provider may hold or adjust your dose

Tell your care team if you notice any of the following. They help your provider decide whether to move up, hold or step back.

-   Nausea or vomiting that stops you eating or drinking normally.
-   Diarrhea or constipation lasting more than a few days.
-   Feeling dizzy, weak or very tired.
-   Injection site reactions that spread or do not settle.
-   Very low appetite that makes it hard to get enough protein and fluids.

Never skip ahead or double up to "catch up". Changing your own dose is one of the main causes of problems with GLP-1 medicines.

## Missed doses

The Zepbound label gives prescribers guidance on missed doses, based on how many days have passed. It also explains how to change your injection day safely.

Compounded programs may give their own instructions. If you miss a dose, check the instructions your provider gave you, or message your care team before you inject. Do not take two doses close together.

## When to get help

Most side effects during titration are mild to moderate. Some need prompt attention.

-   **Seek urgent care** for severe stomach pain that does not go away, with or without vomiting. The label warns about pancreatitis and gallbladder problems.
-   **Seek urgent care** for signs of a serious allergic reaction, such as swelling of the face or throat, or trouble breathing.
-   **Contact your clinician** if you cannot keep fluids down, as dehydration can affect the kidneys.
-   **Contact your clinician** about a lump or swelling in the neck, trouble swallowing or a hoarse voice.

## Reaching a maintenance dose

Titration ends when you and your provider settle on a dose that works. For some people that is a lower step. For others it is higher.

What counts as "working" is a clinical judgment. It weighs side effects, health markers and your goals. Our article on the [tirzepatide maintenance dose](https://telosrx.com/blogs/glp1/tirzepatide-maintenance-dose) explains what the label and research describe.

If progress stalls, a higher dose is not the only lever. Sleep, protein, activity and other medicines all play a part. See [why tirzepatide may not seem to be working](https://telosrx.com/blogs/glp1/tirzepatide-not-losing-weight) for the factors clinicians check.

## Questions to ask your provider about titration

You do not need to memorize a chart. You do need a clear plan. These questions help you get one.

-   What dose am I starting on, and why?
-   How will we decide whether to increase it?
-   Which side effects should I report straight away?
-   What should I do if a step makes me feel unwell?
-   What are the instructions if I miss a dose?
-   How is my product labeled, and how do I give the prescribed dose?

Write the answers down, or keep them in your message history. If anything is unclear, ask again. A good care team would rather answer twice than have you guess.

## Comparing tirzepatide and semaglutide titration

Semaglutide products also start low and step up. The steps and timing differ by product label. If you are switching between medicines, your provider will plan the transition.

For a side-by-side explanation, read our [tirzepatide vs semaglutide dosing guide](https://telosrx.com/blogs/glp1/tirzepatide-vs-semaglutide-dosing-guide).

## How telos rx manages titration

telos rx is an online-first, asynchronous telehealth service. You complete an intake online. A licensed provider reviews it and sets your plan.

As you go, you message your care team about side effects and progress, on your schedule. Your provider uses that feedback to decide when to move up, hold or step back. Every prescription is subject to medical approval by a licensed provider.

Compounded tirzepatide from telos rx is as low as $139 per month, as of 17 November 2026, per the [tirzepatide product page](https://telosrx.com/pages/tirzepatide).

Start with a private online intake

Answer health questions on your schedule. A licensed provider reviews them, and any prescription is subject to medical approval by a licensed provider.

[Check my eligibility](https://telosrx.com/pages/lp2tirzepatide)

## Frequently Asked Questions

### Is there a standard tirzepatide dosing chart?

The Zepbound label describes a standard approach: a low starting dose, then gradual increases spaced at least four weeks apart, up to a maintenance dose. Your prescriber adapts that approach to you. Compounded products can differ in strength, so a generic chart from the internet should never be used to set your own dose.

### Why does tirzepatide start at a low dose?

Starting low gives your digestive system time to adjust. The Zepbound label notes that most nausea, vomiting and diarrhea happened during dose escalation and eased over time. Raising the dose gradually helps limit those effects. Your provider decides when, and whether, each increase makes sense for you.

### Do I have to reach the highest tirzepatide dose?

No. The Zepbound label lists more than one maintenance dose and tells prescribers to consider response and tolerability. Many people stay at a lower dose if it works for them. Your provider weighs side effects, health markers and your goals before deciding whether a higher dose is appropriate.

### Can I use a tirzepatide chart in units or syringe markings?

No. Conversions depend on the exact concentration of your product, which varies between compounded preparations. The FDA has received reports of harm linked to dosing errors with compounded GLP-1 medicines. Follow only the instructions from your prescriber and pharmacy. At telos rx, medication ships ready to inject.

### What if I miss a tirzepatide dose?

The Zepbound label gives prescribers guidance on missed doses based on how many days have passed. Compounded programs may give their own instructions. Check what your provider told you, or message your care team before you inject. Do not take two doses close together to catch up.

### Who decides when to increase my tirzepatide dose?

Your prescriber does. They use the label as a guide, along with your feedback on side effects, appetite and energy. Then they decide whether to move up, hold or step back. With telos rx, you share updates asynchronously by message, and a licensed provider reviews them before any change.

_telos rx is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. telos rx operates as an online-first, asynchronous telehealth service._

Ready to see if it fits? [Start your private evaluation with telos rx](https://telosrx.com/pages/lp2tirzepatide).

**Tags:** cc-152, compounded tirzepatide, content-calendar, dose titration, explainer, GLP-1 dosing, plan-2027, tirzepatide

---

> Source: [Telos RX](https://www.telosrx.com/blogs/glp1/tirzepatide-dosing-chart-titration-explained)
